Skip to search formSkip to main contentSkip to account menu

Lartruvo Injectable Product

National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

50 ML olaratumab 10 MG/ML Injection [Lartruvo]
Injectables

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Olaratumab (LARTRUVO®) as a new therapeutic option in the treatment of patients with advanced soft tissue sarcomas
Olaratumab is a newly approved human monoclonal IgG1 antibody against platelet-derived growth factor alpha (PDGFR-α). In a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)